Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Carl Zeiss Meditec AG buy HOPY96

Start price
€21.00
07.12.12 / 50%
Target price
€24.00
15.02.13
Performance (%)
8.24%
End price
€22.73
15.02.13
Summary
This prediction ended on 15.02.13 with a price of €22.73. The BUY prediction by HOPY96 finished with a performance of 8.24%. HOPY96 has 50% into this prediction

Carl Zeiss Meditec AG is a German-based company that produces medical devices for ophthalmology and microsurgery. It operates in two segments: Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment includes diagnostic and surgical equipment for the anterior and posterior segments of the eye. The Microsurgery segment offers products for neurosurgery, spinal and ENT surgeries, and dental applications. The company has a global reach and serves customers in more than 115 countries through its subsidiaries and distribution network. Carl Zeiss Meditec has been listed on the Frankfurt and TecDAX stock exchanges since 2007.

Performance without dividends (%)
Name 1w 1m 1y 3y
Carl Zeiss Meditec AG -1.212% -1.212% -19.065% -33.390%
iShares Core DAX® 0.000% -2.064% 13.111% 16.685%
iShares Nasdaq 100 0.626% -2.884% 37.744% 43.441%
iShares Nikkei 225® 1.568% -5.892% 19.592% 4.617%
iShares S&P 500 0.334% -2.281% 27.745% 41.046%

Comments by HOPY96 for this prediction

In the thread Carl Zeiss Meditec AG diskutieren
Prediction Buy
Perf. (%) 8.24%
Target price 24.000
Change
Ends at 15.02.13

Nach guten Zahlen....

Nach guten Zahlen, einer um ein Drittel erhöhten Dividende auf 0,40 € kommt Carl Zeiss Meditec deutlich von den Höchstständen runter. Charttechnisch bietet die Basis 20,80/21 kurzfristig Unterstützung. Ein 10%-Trade fürs erste Kursziel sollte reizen.

KAUFEN mit engem SL bei 20,35

 

KZ und SL anheben

Prediction Buy
Perf. (%) 8.24%
Target price 24.000
Change
Ends at 15.02.13

(Stop Loss Kurs erreicht)